DoW Joint Warfighter Medical, Military Medical Research and Development Award
🏛 Defense Health Agency Contracting Activity - DHACA (DOD-AMRAA)
Can you apply?
This grant is for Department of Defense-affiliated researchers and institutions continuing previously funded military medical research. Applicants must have received prior DoD/DoW core or Congressional Special Interest funding to be eligible. The program supports late-stage preclinical studies, technology development, translational research, and clinical research that aligns with FY26 Joint Warfighter Medical Research Program focus areas.
Research projects may involve human subjects, clinical trials, medical devices, or pharmaceuticals. A specialized Clinical Research and Clinical Trial Option (MMRDA-CRCTO) is available for applications involving human subjects or human biological samples.
Program description
Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fund the logical continuation of previous Department of War (DOW)-funded research and development efforts relevant to the FY26 JWMRP that augment and accelerate high-priority medical requirements to meet the needs of Service Members and other Military Health System beneficiaries. The MMRDA supports a wide range of research projects spanning late-stage preclinical studies, late-state technology development efforts, technology demonstration, translational, and clinical research. Projects must be relevant to at least one of the FY26 JWMRP focus areas.
Distinctive Features:
To be eligible for JWMRP funding, applicants/offerors must have already received DOD/DOW core or DOD/DOW Congressional Special Interest funding.
An MMRDA Clinical Research or Clinical Trial Option (MMRDA-CRCTO) is available to specifically support clinical research/observational studies, all phases of clinical trials/interventional studies, and/or correlative studies in support of the development of promising pharmaceutical or biologic candidates, medical devices and technologies. Applicants/offerors should select MMRDA-CRCTO when the application/proposal involves research that includes any human subjects, human biological samples (prospective or retrospective) or human data sets. Note: If selecting this option, applicants must submit additional relevant application/proposal materials.
Who can apply
Eligible applicants
Demographic focus
How to apply
Application links
Key dates & requirements
Required documents
- SF-424 (Application for Federal Assistance)
- Project Narrative/Technical Proposal
- Budget and Budget Justification
- Evidence of Prior DoD/DoW Funding
- Institutional Certifications and Compliance Documents
- Clinical Research Supplementary Materials (if MMRDA-CRCTO option selected)
Program contact
- 👤 Christopher L Baker Grants Officer
- 📧 help@eBRAP.org
- 📞 3016192332
Funding track record
Recent awards under CFDA 12.420 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$2,265,729,366
-
$800,631,761
-
$74,531,880
-
$67,205,571
-
$53,846,370
-
$34,191,124
-
$24,907,742
-
$21,394,379
-
$19,100,256
-
$19,002,641
Top States by Funding
- MD 10 awards $3,150.1M
- NC 11 awards $132.3M
- FL 8 awards $99.8M
- CA 11 awards $99.3M
- TX 8 awards $76.5M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 12.420). How funding has trended year over year.
| 2024 | $1,483,968,520 | |
| 2025 | $1,201,153,417 |
FAQ
Who can apply for this grant?
Applicants must have received prior DoD/DoW core or Congressional Special Interest funding. This is a continuation-focused program for established researchers.
What types of research does this fund?
The program supports late-stage preclinical studies, technology development, translational research, and clinical research relevant to military medical needs and Service Members' health.
Is there a special option for clinical research?
Yes. The MMRDA-CRCTO option is specifically for clinical trials, observational studies, and research involving human subjects or biological samples. Additional materials are required if you select this option.
What is the deadline?
The deadline is November 16, 2026. This is a fixed deadline with no rolling acceptance periods.
Is cost sharing required?
No. Cost sharing is not a requirement for this award mechanism.
💡 Tips for applicants
- Document your prior DoD/DoW funding history clearly. Reviewers verify this eligibility requirement first.
- Align your research objectives directly to at least one stated FY26 JWMRP focus area. Vague connections will weaken your application.
- If your project involves human subjects, use the MMRDA-CRCTO option. Submit all required supplementary materials for this track.
- Demonstrate how your continuation work accelerates high-priority military medical requirements. Focus on impact for Service Members.
- Allow sufficient time for internal approvals and institutional compliance reviews before the November deadline.
⚠️ Common mistakes
Applying without prior DoD/DoW funding. This is an automatic disqualification. Failing to clearly link research to FY26 JWMRP focus areas. Missing required clinical research supplementary materials when selecting MMRDA-CRCTO.
Similar grants
- OPEN U.S. Mission to Canada Alumni Summit — U.S. Mission to Canada
- OPEN DoW Parkinson’s, Investigator-Initiated Research Award — Defense Health Agency Contracting Activity - DHACA
- OPEN DoW Parkinson’s, Early Investigator Research Award — Defense Health Agency Contracting Activity - DHACA
- OPEN DoW Kidney Cancer, Idea Development Award — Defense Health Agency Contracting Activity - DHACA
- OPEN DoW Kidney Cancer, Academy of Kidney Cancer Investigators – Early-Career Scholar Award — Defense Health Agency Contracting Activity - DHACA